- The shares of Vir Biotechnology Inc (NASDAQ: VIR) have received a $125 price target from H.C. Wainwright. These are the details.
The shares of Vir Biotechnology Inc (NASDAQ: VIR) have received a $125 price target from H.C. Wainwright. And H.C. Wainwright analyst Patrick Trucchio is maintaining a “Buy” rating on the shares.
Trucchio had moderated expectations for the COVID-19 franchise. But Trucchio remains positive on Vir shares mainly driven by the strength of the pipeline and $2.5 billion capital positioning.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.
